PAMU
LXRX icon

Pictet Asset Management (UK)’s Lexicon Pharmaceuticals LXRX Stock Holding History

Pictet Asset Management (UK)’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-994,476
Closed -$3.4M – 1824
2020
Q4 		$3.4M Sell
994,476
-57,900
-6% -$110K ﹤0.01% 886
2020
Q3 		$1.51M Sell
1,052,376
-51,900
-5% -$92.4K ﹤0.01% 924
2020
Q2 		$2.2M Sell
1,104,276
-97,800
-8% -$192K ﹤0.01% 851
2020
Q1 		$2.34M Buy
1,202,076
+502,700
+72% +$1.5M 0.01% 826
2019
Q4 		$2.9M Sell
699,376
-30,500
-4% -$117K 0.01% 873
2019
Q3 		$2.2M Buy
729,876
+64,100
+10% +$198K ﹤0.01% 853
2019
Q2 		$4.19M Buy
665,776
+78,926
+13% +$472K 0.01% 740
2019
Q1 		$3.26M Buy
586,850
+175,400
+43% +$1.07M 0.01% 785
2018
Q4 		$2.73M Buy
411,450
+142,200
+53% +$1.15M 0.01% 786
2018
Q3 		$2.87M Sell
269,250
-24,400
-8% -$280K 0.01% 852
2018
Q2 		$3.52M Sell
293,650
-110,000
-27% -$1.13M 0.01% 729
2018
Q1 		$3.46M Buy
403,650
+143,100
+55% +$1.32M 0.01% 723
2017
Q4 		$2.57M Buy
260,550
+185,300
+246% +$1.93M 0.01% 782
2017
Q3 		$925K Buy
75,250
+7,300
+11% +$108K ﹤0.01% 835
2017
Q2 		$941K Buy
67,950
+6,400
+10% +$99.1K ﹤0.01% 823
2017
Q1 		$883K Buy
61,550
+6,800
+12% +$101K ﹤0.01% 822
2016
Q4 		$757K Buy
+54,750
New +$878K ﹤0.01% 812

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pictet Asset Management (UK)'s LXRX Position: Q1 2021 in Review

Pictet Asset Management (UK) sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2021, closing a stake of 994,476 shares — an estimated $3.4M sold.

Pictet Asset Management (UK) first reported a position in LXRX in Q4 2016 and held it in 17 quarters. The position peaked at $4.19M in Q2 2019. 107 funds tracked by Wall St. Rank hold LXRX as of Q1 2021.

  • Pictet Asset Management (UK) reported no remaining Lexicon Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 994,476 Lexicon Pharmaceuticals shares in Q1 2021, an estimated $3.4M.
  • Pictet Asset Management (UK) first reported a position in Lexicon Pharmaceuticals in Q4 2016 and held it in 17 quarters.
  • Pictet Asset Management (UK)'s Lexicon Pharmaceuticals position peaked at $4.19M in Q2 2019.
  • 107 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2021, filed 17 May 2021.